Grassley, Wyden Bill Would Recoup Rebates From Misclassified Drugs

December 05, 2018
The incoming Senate Finance Committee chair and ranking Democrat introduced Tuesday (Dec. 4) a bill to recoup Medicaid rebates from drug companies that misclassify drugs. The bill would let the government fine companies up to twice the amount in rebates they avoid by misclassifying brand drugs as generics, allow CMS to suspend Medicaid coverage of drugs that companies refuse to reclassify, and give CMS power to force classification changes. Finance Chair Chuck Grassley (R-IA) and Sen. Ron Wyden (D-OR) introduced...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.